Neuronetics (STIM) EPS (Basic) (QoQ) (2017 - 2026)
Neuronetics (STIM) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Neuronetics | 121.78 Mn | 115.77 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.24% |
| Dec 31, 2025 | 44.17% |
| Sep 30, 2025 | 34.61% |
| Jun 30, 2025 | -29.10% |
| Mar 31, 2025 | 48.92% |
| Dec 31, 2024 | -33.48% |
| Sep 30, 2024 | 7.41% |
| Jun 30, 2024 | -14.47% |
| Mar 31, 2024 | -38.51% |
| Dec 31, 2023 | 38.90% |
| Sep 30, 2023 | -19.24% |
| Jun 30, 2023 | 26.64% |
| Mar 31, 2023 | -12.98% |
| Dec 31, 2022 | -9.03% |
| Sep 30, 2022 | 21.94% |
| Jun 30, 2022 | 27.90% |
| Mar 31, 2022 | -101.56% |
| Dec 31, 2021 | 41.44% |
| Sep 30, 2021 | 50.25% |
| Jun 30, 2021 | -14.63% |